Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
COMBINATION THERAPIES TO TREAT CHEMORESISTANT CANCERS

No-Receipt date 2020-01231 - 03/04/2020
No-Filing date 20200400957 - 03/04/2020
No-Granting date 3103460 - 22/05/2020
No-EPO application date 13851971.5 - 30/10/2013
No-EPO granting date 2914254 - 08/01/2020
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 5/2020 - 15/06/2020
Expiration date 31/10/2033
Kind of title Validation of European Patent
Legal status NOT VALID
Priorities US201261720346 P30/10/2012/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/245
A61K 31/4184
A61K 31/706
A61K 31/7068
A61K 31/708
A61K 45/06
A61P 35/00

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1141705 MEI PHARMA, INC. 11975 EL CAMINO REAL, SUITE 101SAN DIEGO, CA 92130 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
2892977 GOLD, DANIEL, P.
2892978 GARCIA-MANERO, GUILLERMO

Representatives
CodeFirstnameSurnameAddressTownZip
2864ELISAVETZOULAMOGLOU-VOZEMPERGKZALOKOSTA 38 KAI SYNGROYCHALANDRI (ATTIKIS)15233

Contact
CodeFirstnameSurnameAddressTownZipCountry
7432NIKOLAOSVOZEMPERGK-VRETOSZALOKOSTA 38 KAI SYNGROYCHALANDRI (ATTIKIS)15233 GREECE

Owners History

Title Instruments
DateOperationDescreption
5/8/2023 12:00:00 AMΈκπτωση Κύριων Τίτλων (79602) ΕΚΠΤΩΣΕΙΣ 04/2023 - Αρ. Πρωτ. ΓΔ 1365 / 08.05.23

Payments history 9 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015